LEADER 00000nam a2200445 i 4500 
001    978-981-10-3886-0 
003    DE-He213 
005    20180104170806.0 
006    m     o  d         
007    cr nn 008maaau 
008    170614s2017    si      s         0 eng d 
020    9789811038860|q(electronic bk.) 
020    9789811038853|q(paper) 
024 7  10.1007/978-981-10-3886-0|2doi 
040    GP|cGP|erda 
041 0  eng 
050  4 RJ411 
082 04 618.9215|223 
245 00 Hematological disorders in children :|bpathogenesis and 
       treatment /|cedited by Eiichi Ishii 
264  1 Singapore :|bSpringer Singapore :|bImprint: Springer,
       |c2017 
300    1 online resource (x, 269 pages) :|billustrations, digital
       ;|c24 cm 
336    text|btxt|2rdacontent 
337    computer|bc|2rdamedia 
338    online resource|bcr|2rdacarrier 
347    text file|bPDF|2rda 
505 0  Part I: Hematopoiesis -- Hematopoietic Stem Cells -- Part 
       II: White Blood Cell Disorders -- Acute Lymphoblastic 
       Leukemia -- Acute Myeloid Leukemia -- Myelodysplastic 
       syndrome and JMML -- Leukopenia (neutropenia) -- Part III:
       Red Blood Cell Disorders -- Aplastic Anemia -- Bone marrow
       failure, TAM -- Part IV: Platelet and Coagulation 
       Disorders -- Immune and inherited thrombocytopenia -- 
       Hemophilia -- Thrombosis -- Part V: Histiocytic Disorders 
       -- Langerhans Cell Histiocytosis -- Hemophagocytic 
       Lymphohistiocytosis, primary -- Hemophagocytic 
       Lymphohistiocytosis, secondary 
520    This book describes the pathogenesis and treatment of 
       several representative hematological disorders in children,
       with a special focus on genetic and molecular aspects. 
       Research on the pathogenesis of hematological disorders in
       children has made remarkable strides; especially molecular
       target therapy has shown outstanding effects in refractory
       and conventional therapies for childhood leukemia. The 
       findings presented in this book will broaden readers' 
       understanding and hopefully spark new discussions leading 
       to the development of new therapies including cell therapy
       and molecular target therapy, allowing clinicians to use 
       more effective and less toxic approaches in the future. 
       Hematological Disorders in Children will appeal to a wide 
       readership, from medical students and beginning 
       investigators to experienced scholars in the field of 
       pediatric hematology and oncology seeking to broaden their
       understanding and keep up with the latest developments. It
       will also be of interest to the parents of pediatric 
       patients, and to co-medical staffs 
650  0 Pediatric hematology 
650 14 Medicine & Public Health 
650 24 Hematology 
650 24 Pediatrics 
650 24 Oncology 
700 1  Ishii, Eiichi,|eeditor 
710 2  SpringerLink (Online service) 
773 0  |tSpringer eBooks 
856 40 |uhttp://dx.doi.org/10.1007/978-981-10-3886-0
       |zeBook(Springerlink)